44 pending office actions • 29 art units • 41 examiners • 0 of 44 (0%) have an AI response strategy ready • 30 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 16 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 16 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (9%) |
| §103 only | 12 (27%) |
| §102 only | 1 (2%) |
| §112 only | 5 (11%) |
| Multi-statute (no §101) | 22 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SZNAIDMAN, MARCOS L | 2 | 37.2% | +16.0% |
| LEONARD, ARTHUR S | 2 | 50.9% | +50.5% |
| MIDDLETON, DANAYA L | 2 | 46.1% | +54.1% |
| YANG, JEFFREY ANDREW | 1 | 85.7% | +26.3% |
| LEBOEUF, JEROME LARRY | 1 | 85.2% | +7.2% |
| ROMERO, KRISTEN WANG | 1 | 70.7% | +30.0% |
| TOTH, KAREN E | 1 | 46.7% | +25.4% |
| COUGHLIN, DANIEL F | 1 | 39.0% | +18.5% |
| YOUNGBLOOD, WILLIAM JUSTIN | 1 | 61.9% | +40.0% |
| HO, WAI-GA DAVID | 1 | 14.3% | +100.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19071967 | FOUNDATION MODEL FOR ERROR CORRECTION CODES AND LEARNING LINEAR BLOCK ERROR CORRECTION CODES | YANG, JEFFREY ANDREW | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17780536 | COMPOSITION-OF-MATTER FOR EXTRUSION OF ELECTROCHEMICAL SYSTEM | SMITH, JEREMIAH R | 42d overdue |
| 17675910 | PEPTIDES FOR THE TREATMENT OF RENAL DISORDERS | COFFA, SERGIO | 30d overdue |
| 18605474 | COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASE | NEAGU, IRINA | 4d overdue |
| 17870029 | MOLECULES AND METHODS FOR INCREASED TRANSLATION | ABBOTT, KODYE LEE | 12d |
| 17831232 | INTEGRATED DRUG DISCOVERY PLATFORM FOR PROTEIN MISFOLDING DISORDERS ASSOCIATED WITH METABOLITE ACCUMULATION | PERSONS, JENNA L | 13d |
| 18701978 | ANTIREFLECTIVE COATING AND USES THEREOF | HO, WAI-GA DAVID | 14d |
| 18110960 | METHOD AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS | WANG, CHANG YU | 16d |
| 18869977 | CUMULATIVE POLARIZATION COEXISTING WITH CONDUCTIVITY AT INTERFACIAL FERROELECTRICS | LEBOEUF, JEROME LARRY | 21d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18701978 | ANTIREFLECTIVE COATING AND USES THEREOF | HO, WAI-GA DAVID | 14d |
| 19071967 | FOUNDATION MODEL FOR ERROR CORRECTION CODES AND LEARNING LINEAR BLOCK ERROR CORRECTION CODES | YANG, JEFFREY ANDREW | — |
| 18768262 | COMPOUNDS FOR THE TREATMENT OF GLYCOGEN STORAGE DISORDERS | ROMERO, KRISTEN WANG | — |
| 18742987 | METHODS FOR DETECTING AND PREVENTING ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT | TOTH, KAREN E | — |
| 18674990 | METHODS AND COMPOSITIONS FOR TREATING SPINAL CORD INJURY | COUGHLIN, DANIEL F | — |
| 18710002 | FLUCONAZOLE-COX INHIBITOR HYBRIDS: A DUAL-ACTING CLASS OF ANTIFUNGAL AZOLES | YOUNGBLOOD, WILLIAM JUSTIN | — |
| 18277257 | LYSOSOME-ASSOCIATED MEMBRANE PROTEIN TARGETING COMPOUNDS AND USES THEREOF | SZNAIDMAN, MARCOS L | — |
| 18245970 | COMBINATION COMPOSITIONS HAVING ANTI-VIRAL ACTIVITIES AND USES THEREOF | SZNAIDMAN, MARCOS L | — |
| Art Unit | Apps |
|---|---|
| 3791 | 3 |
| 1631 | 3 |
| 1628 | 2 |
| 1637 | 2 |
| 1723 | 2 |
| 1674 | 2 |
| 1675 | 2 |
| 2824 | 1 |
| 1619 | 1 |
| 2872 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19071967 | FOUNDATION MODEL FOR ERROR CORRECTION CODES AND LEARNING LINEAR BLOCK ERROR CORRECTION CODES | YANG, JEFFREY ANDREW | — | §103 | Non-Final OA | — | Pending | Mar 06, 2025 |
| 18869977 | CUMULATIVE POLARIZATION COEXISTING WITH CONDUCTIVITY AT INTERFACIAL FERROELECTRICS | LEBOEUF, JEROME LARRY | 2824 | §103§112 | Final Rejection | 21d | Pending | Nov 27, 2024 |
| 18768262 | COMPOUNDS FOR THE TREATMENT OF GLYCOGEN STORAGE DISORDERS | ROMERO, KRISTEN WANG | — | §103§112 | Non-Final OA | — | Pending | Jul 10, 2024 |
| 18742987 | METHODS FOR DETECTING AND PREVENTING ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT | TOTH, KAREN E | 3791 | §101§103§112 | Non-Final OA | — | Pending | Jun 13, 2024 |
| 18674990 | METHODS AND COMPOSITIONS FOR TREATING SPINAL CORD INJURY | COUGHLIN, DANIEL F | 1619 | §102Other | Non-Final OA | — | Pending | May 27, 2024 |
| 18710002 | FLUCONAZOLE-COX INHIBITOR HYBRIDS: A DUAL-ACTING CLASS OF ANTIFUNGAL AZOLES | YOUNGBLOOD, WILLIAM JUSTIN | — | §102§112 | Non-Final OA | — | Pending | May 14, 2024 |
| 18701978 | ANTIREFLECTIVE COATING AND USES THEREOF | HO, WAI-GA DAVID | 2872 | §103 | Non-Final OA | 14d | Pending | Apr 17, 2024 |
| 18694614 | CANNABINOID-LIPID CONJUGATES, METHODS FOR PRODUCING THE SAME AND USES THEREOF | FETTEROLF, BRANDON J | 1626 | §112 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18605474 | COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASE | NEAGU, IRINA | 1629 | §102§103§112Other | Non-Final OA | 4d overdue | Pending | Mar 14, 2024 |
| 18419732 | DIGITAL MICROFLUIDICS-LIKE MANIPULATION OF ELECTROKINETICALLY PRECONCENTRATED BIOPARTICLE/BIOMOLECULE PLUGS IN CONTINUOUS-FLOW | HERBERT, MADISON TAYLOR | — | §102§103§112 | Non-Final OA | — | Pending | Jan 23, 2024 |
| 18573517 | COMBINATION COMPOSITIONS FOR THE TREATMENT OF PATHOGEN INFECTIONS AND ASSOCIATED COMPLICATIONS | LIEB, JEANETTE M | 1654 | §103 | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18563388 | HIGH FREQUENCY SENSITIVE NEURAL NETWORK | DANG, PHILIP | — | §103 | Final Rejection | — | Pending | Nov 22, 2023 |
| 18277257 | LYSOSOME-ASSOCIATED MEMBRANE PROTEIN TARGETING COMPOUNDS AND USES THEREOF | SZNAIDMAN, MARCOS L | 1628 | §112 | Non-Final OA | — | Pending | Aug 15, 2023 |
| 18263795 | LIPIDS SUITABLE FOR NUCLEIC ACID DELIVERY | SAWYER, JENNIFER C | 1691 | §103 | Non-Final OA | — | Pending | Aug 01, 2023 |
| 18038534 | OPTIMIZED WOUND SITE OFFLOADING FOOTWEAR | HALPRIN, MOLLY SARA | 3791 | §103 | Final Rejection | 121d overdue | Pending | May 24, 2023 |
| 18310044 | GATA6-AS1 lncRNA FOR USE IN THERAPY | GROOMS, TIFFANY NICOLE | 1637 | §101§103§112 | Non-Final OA | 70d | Pending | May 01, 2023 |
| 18245970 | COMBINATION COMPOSITIONS HAVING ANTI-VIRAL ACTIVITIES AND USES THEREOF | SZNAIDMAN, MARCOS L | 1628 | §101§103 | Non-Final OA | — | Pending | Mar 20, 2023 |
| 18123413 | METHOD AND SYSTEM FOR DESIGNING POLYNUCLEOTIDE SEQUENCES AND POLYNUCLEOTIDE SEQUENCES OBTAINED THEREBY | LEONARD, ARTHUR S | 1631 | §102§103§112 | Non-Final OA | — | Pending | Mar 20, 2023 |
| 18184249 | METHOD FOR DETECTION OF MICROORGANISMS | RODRIGUEZ-GARCIA, VALERIE | 1621 | §112 | Final Rejection | — | Pending | Mar 15, 2023 |
| 18021577 | MRI IN AN INHOMOGENEOUS FIELD WITH NO PULSED GRADIENTS | CRUZ, IRIANA | 2681 | §102§103 | Non-Final OA | 56d | Pending | Feb 16, 2023 |
| 18002251 | COMPOSITIONS COMPRISING AROMATIC DIPEPTIDES-BASED STRUCTURES ENCAPSULATING AN ESTERASE AND USES THEREOF | RAMIREZ, DELIA M | 1652 | §103§112Other | Final Rejection | — | Pending | Dec 16, 2022 |
| 17988893 | MAdCAM-1 POLYPEPTIDES AND USES THEREOF | LOCKARD, JON MCCLELLAND | 1647 | §103§112 | Non-Final OA | — | Pending | Nov 17, 2022 |
| 17921035 | CHIMERIC POLYPEPTIDES AND METHODS OF PREPARING SAME | HOLLAND, PAUL J | 1656 | §112 | Final Rejection | 13d | Pending | Oct 24, 2022 |
| 17995610 | CONCURRENT ELECTROPHORETIC DEPOSITION OF MEMBRANE-ELECTRODE-ASSEMBLY | ROLDAN RAMOS, CHRISTIAN | 1723 | §103 | Final Rejection | 42d overdue | Pending | Oct 06, 2022 |
| 17952387 | SYSTEM AND METHOD FOR MAPPING MUSCULAR ACTIVATION | GLOVER, NELSON ALEXANDER | 3791 | §102§103§112 | Final Rejection | — | Pending | Sep 26, 2022 |
| 17800345 | ANTI- MUC1-SEA ANTIBODIES | MIDDLETON, DANAYA L | 1674 | §102§112 | Non-Final OA | — | Pending | Aug 17, 2022 |
| 17870607 | RIBOSOME TERMINATION STRUCTURES AND USE THEREOF | SHIBUYA, MARK LANCE | 1631 | §103§112 | Non-Final OA | — | Pending | Jul 21, 2022 |
| 17870029 | MOLECULES AND METHODS FOR INCREASED TRANSLATION | ABBOTT, KODYE LEE | 1634 | §102§103§112 | Non-Final OA | 12d | Pending | Jul 21, 2022 |
| 17788003 | METHODS AND ARRAYS FOR IDENTIFYING THE CELL OR TISSUE ORIGIN OF DNA | LAFAVE, ELIZABETH ROSE | 1684 | §103 | Final Rejection | — | Pending | Jun 22, 2022 |
| 17783276 | BACTERIA-ASSOCIATED VOLATILE ORGANIC COMPOUNDS | BOECKELMAN, JACOB A | 1655 | §101§112 | Final Rejection | — | Pending | Jun 08, 2022 |
| 17831232 | INTEGRATED DRUG DISCOVERY PLATFORM FOR PROTEIN MISFOLDING DISORDERS ASSOCIATED WITH METABOLITE ACCUMULATION | PERSONS, JENNA L | 1637 | §102§112Other | Non-Final OA | 13d | Pending | Jun 02, 2022 |
| 17780536 | COMPOSITION-OF-MATTER FOR EXTRUSION OF ELECTROCHEMICAL SYSTEM | SMITH, JEREMIAH R | 1723 | §102§103 | Non-Final OA | 42d overdue | Pending | May 27, 2022 |
| 17637682 | METHODS AND COMPOSITIONS FOR TREATING PAX6-DEFICIENCY RELATED DISEASE | PATTERSON, SARAH COOPER | 1675 | §112 | Final Rejection | — | Pending | Feb 23, 2022 |
| 17675910 | PEPTIDES FOR THE TREATMENT OF RENAL DISORDERS | COFFA, SERGIO | 1658 | §103§112 | Non-Final OA | 30d overdue | Pending | Feb 18, 2022 |
| 17394008 | MESENCHYMAL CELL-DERIVED EXOSOMES TO TREAT NEUROLOGICAL DISORDERS | BARRON, SEAN C | 1653 | §103§112Other | Final Rejection | 34d | Pending | Aug 04, 2021 |
| 17273857 | METHOD OF PRODUCING METAL NANOPARTICLES AND USES THEREOF | PURDY, KYLE A | 1611 | §103 | Non-Final OA | 27d | Pending | Mar 05, 2021 |
| 17142072 | METHODS AND COMPOSITIONS FOR MODULATING MYELOPEROXIDASE (MPO) EXPRESSION | MIDDLETON, DANAYA L | 1674 | §102§112Other | Non-Final OA | — | Pending | Jan 05, 2021 |
| 16959878 | TRANSGENIC EUKARYOTIC ORGANISMS AND METHODS FOR GENDER SELECTION | LEONARD, ARTHUR S | 1631 | §103 | Final Rejection | — | Pending | Jul 02, 2020 |
| 16919134 | CONTROL OF THE CONCENTRATION-POLARIZATION LAYER LENGTH IN A MICROCHANNEL-MEMBRANE SYSTEM | KOLTONOW, ANDREW ROBERT | 1795 | §103§112 | Final Rejection | 22d | Pending | Jul 02, 2020 |
| 18570211 | MULTI-LAYERED MODULAR ORGAN-ON-A-CHIP PLATFORM | CARREON, ADRIAN JOHN | — | §103 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18223730 | COMPOSITIONS AND METHODS FOR TREATING A DISEASE | JOHANSEN, PETER N. | 1644 | §102§103 | Final Rejection | — | Pending | Jul 19, 2023 |
| 18110960 | METHOD AND PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS | WANG, CHANG YU | 1675 | §103§112 | Non-Final OA | 16d | Pending | Feb 17, 2023 |
| 18110934 | ENGINEERED PROTEIN DELIVERY PLATFORM AND USE THEREOF FOR ANTIBACTERIAL TREATMENTS | KANE, TREVOR LOGAN | 1657 | §103§112Other | Final Rejection | — | Pending | Feb 17, 2023 |
| 18167381 | HIGH DIMENSIONAL SURROGATE MODELING FOR LEARNING UNCERTAINTY | WU, NICHOLAS S | 2148 | §103 | Final Rejection | — | Pending | Feb 10, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial